6
1
110
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T11344 | G150 | DNA , cGAS | |
G150 inhibited interferon expression triggered by DSDNA with IC50 of 10.2 nM.G150 is an effective and highly selective inhibitor of human cyclic GMP-AMP synthase (H-CGAS). | |||
T4531 | GSK2200150A | Antibacterial | |
GSK2200150A is an anti-tuberculosis (TB) agent identified by high-throughput screening (HTS) campaign. | |||
T4062 | CAY10602 | Sirtuin | |
CAY10602 is a SIRT1 activator. CAY10602 was derived from high throughput screening for compounds that increase SIRT1-mediated deacetylation of a SIRT1-specific substrate. Functional assays show that CAY10602 dose-depende... | |||
T83800 | 6-Biotin-17-NAD+ sodium | 6-Biotin-17-Nicotinamide adenine dinucleotide,β-Nicotinamide-N6-(2-(6-(6-[biotinyl]aminohexanoyl)aminohexanoyl)aminoethyl)adenine dinucleotide | |
6-Biotin-17-NAD+, a biotinylated derivative of the signaling molecule and enzyme cofactor NAD+, is utilized in high-throughput screening (HTS) assays to measure the activity of mitochondrial complex I, also referred to a... | |||
T37062 | L-Leucine-7-amido-4-methylcoumarin hydrochloride | ||
L-Leu-AMC is a fluorogenic substrate for leucine aminopeptidase.1Upon enzymatic cleavage by leucine aminopeptidase, AMC is released and its fluorescence can be used to quantify leucine aminopeptidase activity. AMC displa... | |||
T83952 | CoraFluor 1, amine reactive | ||
CoraFluor 1, an amine-reactive terbium-based compound, serves as a potent donor in time-resolved Förster resonance energy transfer (TR-FRET) assays, including applications in target engagement and ternary complex assessm... |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T3313 | D-Luciferin | Firefly luciferin,D-(-)-Luciferin | Others |
D-Luciferin (D-(-)-Luciferin) is a popular bioluminescent substrate of luciferase in the presence of ATP, used in luciferase-based bioluminescence imaging and cell-based high-throughput screening applications. |
カタログ番号 | 製品名 | ||
---|---|---|---|
L7000 | Bioactive Lipid Compound Library | 385 compounds | |
A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, ... | |||
L1000 | Approved Drug Library | 2808 compounds | |
A unique collection of 2808 approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L6100 | Polyphenolic Natural Product Library | 635 compounds | |
A unique collection of 635 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L3900 | DNA Damage & Repair Compound Library | 910 compounds | |
A unique collection of 910 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L3410 | Preclinical Compound Library | 701 compounds | |
A unique collection of 701 preclinical compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L2000 | Inhibitor Library | 8328 compounds | |
A unique collection of 8328 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L2400 | Endocrinology-Hormone Compound Library | 784 compounds | |
A unique collection of 784 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L5500 | Toxic Compound Library | 262 compounds | |
A unique collection of 262 toxic substances for high throughput screening (HTS) and high content screening (HCS); | |||
L1200 | Epigenetics Compound Library | 953 compounds | |
Well-chosen 953 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L2120 | Anti-Cancer Clinical Compound Library | 2545 compounds | |
A unique collection of 2545 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L1510 | Nuclear Receptor Compound Library | 531 compounds | |
A unique collection of 531 nuclear receptor signaling targeted compounds for high throughput and high content screening; | |||
L2800 | Serotonin Receptor-Targeted Compound Library | 268 compounds | |
A unique collection of 268 compounds targeting serotonin receptors for high throughput screening and high content screening; | |||
L3600 | Cytokine Inhibitor Library | 604 compounds | |
A unique collection of 604 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery; | |||
L8000 | Stem Cell Differentiation Compound Library | 1197 compounds | |
A unique collection of 1197 stem cell differentiation signaling targeted compounds for high throughput and high content screening; | |||
L5400 | Anti-Cardiovascular Disease Compound Library | 1408 compounds | |
A unique collection of 1408 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L2910 | Antioxidant Compound Library | 1314 compounds | |
Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. ... | |||
L4100 | TGF-beta/Smad Compound Library | 184 compounds | |
A unique collection of 184 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening; | |||
L3700 | JAK-STAT Compound Library | 252 compounds | |
A unique collection of 252 JAK/STAT signaling targeted compounds for high throughput and high content screening; | |||
L6610 | Anti-infective Natural Product Library | 1060 compounds | |
A unique collection of 1060 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS); | |||
L2600 | Neuronal Signaling Compound Library | 2540 compounds | |
A unique collection of 2540 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L8300 | Chromatin Modification Compound Library | 250 compounds | |
A unique collection of 250 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS); | |||
L4200 | FDA-Approved Drug Library | 1729 compounds | |
A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L3980 | DNA Damage and Repair Compound Library Plus | 667 compounds | |
Well-chosen 667 compounds with unique structures targeting DNA damage & repair; | |||
L6300 | Food as Medicine Compound Library | 1290 compounds | |
A unique collection of 1290 compounds from food as medicine for high throughput and high content screening; | |||
L6230 | Miao medicine Compound Library | 534 compounds | |
A unique collection of 534 compounds featuring natural product molecules derived from Miao medicine that can be used for high-throughput and high-content screening. | |||
L8400 | Hematonosis Compound Library | 514 compounds | |
A unique collection of 514 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS); | |||
L5200 | Anti-Metabolism Disease Compound Library | 1544 compounds | |
A unique collection of 1544 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L2300 | Ion Channel Inhibitor Library | 931 compounds | |
A unique collection of 931 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery; | |||
L6010 | Natural Product Library | 3840 compounds | |
A unique collection of 3840 natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L2130 | Anti-Cancer Metabolism Compound Library | 1268 compounds | |
A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | |||
L6030 | Natural Product Derivatives Library for CADD | 163000 compounds | |
Large quantity: contains 163,000 natural product derivatives and the number is continuously updating; | |||
L4300 | Wnt/Hedgehog/Notch Compound Library | 237 compounds | |
A unique collection of 237 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening; | |||
L6220 | Traditional Mongolian Medicine Compound Library | 950 compounds | |
A collection of 950 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening. | |||
L3800 | NF-κB Signaling Compound Library | 729 compounds | |
A unique collection of 729 compounds targeting NF-κB signaling for high throughput screening and high content screening; | |||
L3400 | Clinical Compound Library | 3404 compounds | |
A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS); | |||
L1800 | Anti-Infection Compound Library | 2938 compounds | |
A unique collection of 2938 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc; | |||
L2140 | Cancer Cell Differentiation Compound Library | 406 compounds | |
A unique collection of 406 cancer cell differentiation inducing compounds for high throughput and high content screening; | |||
LF1000 | Pre-plated Diversity Sets | 50000 compounds | |
For your convenience, there are Diversity Sets of 5,000, 10,000, 15,000, and 20,000 compounds with no structure overlap. | |||
L3100 | Hematopoietic Toxicity Compound Library | 101 compounds | |
A unique collection of 101 compounds with defined hematopoietic toxicity for high throughput and high content drug screening; | |||
L9200 | Drug Repurposing Compound Library | 4630 compounds | |
A unique collection of 4630 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L1600 | Kinase Inhibitor Library | 2720 compounds | |
A unique collection of 2720 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases; | |||
L5800 | Drug Metabolite/Impurity Library | 197 compounds | |
A unique collection of 197 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS); | |||
L1300 | PI3K-AKT-mTOR Compound Library | 420 compounds | |
A unique collection of 420 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling; | |||
L9850 | Orally Active Compound Library | 2427 compounds | |
A unique collection of 2427 of orally active compounds for high-throughput screening and high-content screening. | |||
L3500 | Histone Modification Compound Library | 469 compounds | |
A unique collection of 469 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L2200 | Tyrosine Kinase Inhibitor Library | 1016 compounds | |
A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases; | |||
L4020 | NO PAINS Compound Library | 9384 compounds | |
L9230 | ReFRAME Related Library | 3210 compounds | |
A unique collection of 3210 compounds for high-throughput screening and high-content screening, | |||
L6600 | Anti-Gastroenteritis Natural Product Library | 219 compounds | |
A unique collection of 219 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS); | |||
L8100 | Cell Cycle Compound Library | 677 compounds | |
A unique collection of 677 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L4000 | Bioactive Compound Library | 14439 compounds | |
A collection of 14439 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification; | |||
L2150 | Anti-Cancer Drug Library | 3080 compounds | |
A unique collection of 3080 anticancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L2160 | Anti-Cancer Active Compound Library | 3188 compounds | |
A unique collection of 3188 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L6210 | Tibetan medicine Compound Library | 747 compounds | |
A collection of 747 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening. | |||
L2900 | Oxidation-Reduction Compound Library | 1264 compounds | |
1264 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening. | |||
L2195 | Anti-Prostate Cancer Compound Library | 2070 compounds | |
2070 compounds associated with prostate cancer that can be used for high-throughput and high-content screening. | |||
L6900 | Rare Natural Product Library | 693 compounds | |
A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS); | |||
L2100 | Anti-Cancer Compound Library | 7234 compounds | |
A unique collection of 7234 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L1010 | FDA-Approved & Pharmacopeia Drug Library | 3158 compounds | |
3158 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L6700 | Anti-Tumor Natural Product Library | 1772 compounds | |
A unique collection of 1772 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L1610 | FDA-Approved Kinase Inhibitor Library | 263 compounds | |
A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening. | |||
L9610 | Cyclic Peptide Library | 55 compounds | |
55 species of cyclic peptide molecules for high-throughput and high-content screening; | |||
L6130 | Terpene Natural Product Library | 516 compounds | |
A unique collection of 516 natural terpenes and terpenoids can be used for high throughput and high content screening; | |||
L1700 | Anti-Viral Compound Library | 1040 compounds | |
A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening; | |||
L5900 | CNS-Penetrant Compound Library | 509 compounds | |
A unique collection of 509 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L9210 | Pediatric Drug Library | 972 compounds | |
A unique collection of 972 pediatric drugs for high-throughput screening and high-content screening. | |||
L8200 | Anti-Aging Compound Library | 3279 compounds | |
A unique collection of 3279 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L1500 | GPCR Compound Library | 1940 compounds | |
A unique collection of 1940 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research; | |||
L2152 | Targeted Therapy Drug Library | 119 compounds | |
119 tumor-targeted drugs that can be used for high-throughput and high-content screening. | |||
L2521 | Glycolysis Compound Library | 555 compounds | |
555 glycolysis-related active compounds for high-throughput and high-content screening. | |||
L3200 | Autophagy Compound Library | 1248 compounds | |
A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L2570 | Human Metabolite Library | 4454 compounds | |
A unique collection of 4454 human metabolites for high-throughput, high-content screening. | |||
L4600 | Selected Plant-Sourced Compound Library | 3048 compounds | |
A unique collection of 3048 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS); | |||
L6620 | Antiparasitic Natural Product Library | 253 compounds | |
A unique collection of 253 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS); | |||
L7400 | Sodium Channel Blocker Library | 118 compounds | |
A unique collection of 118 sodium channel blockers and agonists for high throughput and high content screening; | |||
L2500 | Human Endogenous Metabolite Library | 499 compounds | |
A collection of 499 selected human endogenous metabolites for high throughput and high content screening. | |||
L7700 | Neural Regeneration Compound Library | 524 compounds | |
A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening; | |||
L7200 | Calcium Channel Compound Library | 140 compounds | |
A unique collection of 140 calcium channel blockers and agonists for high throughput and high content screening; | |||
L7900 | Osteogenesis Compound Library | 317 compounds | |
A unique collection of 317 osteogenesis related compounds for high throughput and high content screening; | |||
L7300 | Potassium Channel Blocker Library | 152 compounds | |
A unique collection of 152 potassium channel blockers and agonists for high throughput and high content screening; | |||
L2151 | Chemotherapy Drug Library | 48 compounds | |
48 Chemotherapeutic drugs that can be used for high-throughput and high-content screening. | |||
L8600 | Ubiquitination Compound Library | 210 compounds | |
A unique collection of 210 ubiquitination related small chemicals can be used for high throughput and high content screening; | |||
L2110 | Anti-Cancer Approved Drug Library | 1779 compounds | |
A unique collection of 1779 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L4800 | Angiogenesis related Compound Library | 1353 compounds | |
A unique collection of 1353 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS); | |||
L6200 | The Yao nationality medicine Library | 221 compounds | |
A collection of 221 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening. | |||
L2194 | Anti-Colorectal Cancer Compound Library | 1545 compounds | |
1545 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening. | |||
L4710 | Nonsteroidal Anti-Inflammatory Compound Library | 530 compounds | |
530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening. | |||
L7500 | Coagulation and Anticoagulation Compound Library | 144 compounds | |
A unique collection of 144 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L6400 | Marine Natural Product Library | 144 compounds | |
A unique collection of 144 marine natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L2560 | Metabolism Compound Library | 2320 compounds | |
L8720 | Pyroptosis Compound Library | 1066 compounds | |
1066 types of active small molecules associated with pyroptosis for high-throughput and high-content screening. | |||
L3300 | Histamine & Melatonin Receptor-Targeted Compound Library | 153 compounds | |
A unique collection of 153 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L4010 | Bioactive Compounds Library Max | 22555 compounds | |
A collection of 22555 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification. | |||
L6500 | Microbial Natural Product Library | 550 compounds | |
A unique collection of 550 microbial natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L2510 | Lipid Metabolism Compound Library | 492 compounds | |
A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | |||
L6820 | Tobacco Monomer Library | 747 compounds | |
L9700 | Endoplasmic Reticulum Stress Compound Library | 193 compounds | |
A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS); | |||
L4700 | Immunology/Inflammation Compound Library | 4720 compounds | |
A unique collection of 4720 anti-inflammation compounds effective for high throughput screening and high content screening. | |||
L8110 | Reprogramming Compound Library | 1813 compounds | |
A unique collection of 1813 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | |||
L7600 | Chemokine Inhibitor Library | 59 compounds | |
A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening; | |||
L3510 | Methylation Compound Library | 128 compounds | |
128 methylation-related compounds that can be used for high-throughput and high-content screening. | |||
L6110 | Alkaloid Natural Product Library | 464 compounds | |
A unique collection of 464 natural alkaloids can be used for high throughput and high content screening; | |||
L9860 | Antidepressant Compound Library | 1163 compounds | |
1163 compounds associated with depression that can be used for high-throughput and high-content screening | |||
L6120 | Flavonoid Natural Product Library | 514 compounds | |
A unique collection of 514 flavonoids can be used for high throughput and high content screening; | |||
L9420 | Exosome Compound Library | 76 compounds | |
76 exosome-related compounds that can be used for high-throughput and high-content screening. | |||
L7100 | Anti-Obesity Compound Library | 2247 compounds | |
A unique collection of 2247 anti-obesity compounds for high throughput and high content screening; | |||
L2550 | Glutamine Metabolism Compound Library | 565 compounds | |
A unique collection of 565 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and ... | |||
L2170 | Immuno-Oncology Compound Library | 449 compounds | |
A unique collection of 449 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening; | |||
L7110 | Anti-Hypertension Compound Library | 678 compounds | |
678 hypertension-related small molecules for high-throughput and high-content screening. | |||
L9300 | Macrocyclic Compound Library | 210 compounds | |
210 macrocyclic compounds of known activity for high-throughput, high-content screening; |